|
[1]
|
Niu, L. (2020) Fungal Keratitis: Pathogenesis, Diagnosis and Prevention. Microbial Pathogenesis, 138, Article ID: 103802.
|
|
[2]
|
Mahmoudi, S., Masoomi, A., Ahmadikia, K., Tabatabaei, S.A., Soleimani, M., Rezaie, S., et al. (2018) Fungal Keratitis: An Overview of Clinical and Laboratory Aspects. Mycoses, 61, 916-930. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lakhundi, S., Siddiqui, R. and Khan, N.A. (2017) Pathogenesis of Microbial Keratitis. Microbial Pathogenesis, 104, 97-109. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Madeira, J.M., Gibson, D.L., Kean, W.F. and Klegeris, A. (2012) The Biological Activity of Auranofin: Implications for Novel Treatment of Diseases. Inflammopharmacology, 20, 297-306. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kim, N., Lee, M., Park, S., Choi, J., Oh, M. and Kim, I. (2007) Auranofin Blocks Interleukin‐6 Signalling by Inhibiting Phosphorylation of JAK1 and Stat3. Immunology, 122, 607-614. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kim, N., Oh, M., Park, H.J. and Kim, I. (2010) Auranofin, a Gold(I)-Containing Antirheumatic Compound, Activates Keap1/Nrf2 Signaling via Rac1/iNOS Signal and Mitogen-Activated Protein Kinase Activation. Journal of Pharmacological Sciences, 113, 246-254. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Stern, I., Wataha, J.C., Lewis, J.B., Messer, R.L.W., Lockwood, P.E. and Tseng, W.Y. (2005) Anti-Rheumatic Gold Compounds as Sublethal Modulators of Monocytic LPS-Induced Cytokine Secretion. Toxicology in Vitro, 19, 365-371. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Han, S., Kim, K., Kim, H., Kwon, J., Lee, Y., Lee, C., et al. (2008) Auranofin Inhibits Overproduction of Pro-Inflammatory Cytokines, Cyclooxygenase Expression and PGE2 Production in Macrophages. Archives of Pharmacal Research, 31, 67-74. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Jeon, K., Jeong, J. and Jue, D. (2000) Thiol-Reactive Metal Compounds Inhibit NF-κB Activation by Blocking IκB Kinase. The Journal of Immunology, 164, 5981-5989. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Park, S. and Kim, I. (2005) The Role of P38 MAPK Activation in Auranofin‐Induced Apoptosis of Human Promyelocytic Leukaemia HL‐60 Cells. British Journal of Pharmacology, 146, 506-513. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Garg, P., Roy, A. and Roy, S. (2016) Update on Fungal Keratitis. Current Opinion in Ophthalmology, 27, 333-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Shen, S., Shen, J., Luo, Z., Wang, F. and Min, J. (2023) Molecular Mechanisms and Clinical Implications of the Gold Drug Auranofin. Coordination Chemistry Reviews, 493, Article ID: 215323. [Google Scholar] [CrossRef]
|
|
[13]
|
Zhan, L., Peng, X., Lin, J., Zhang, Y., Gao, H., Zhu, Y., et al. (2020) Honokiol Reduces Fungal Load, Toll-Like Receptor-2, and Inflammatory Cytokines in aspergillus Fumigatus Keratitis. Investigative Opthalmology & Visual Science, 61, Article No. 48. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Al-Kharashi, L.A., Al-Harbi, N.O., Ahmad, S.F., Attia, S.M., Algahtani, M.M., Ibrahim, K.E., et al. (2023) Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing-Remitting EAE. Biomedicines, 11, Article No. 2502. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Hybertson, B.M., Gao, B., Bose, S.K. and McCord, J.M. (2011) Oxidative Stress in Health and Disease: The Therapeutic Potential of Nrf2 Activation. Molecular Aspects of Medicine, 32, 234-246. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Tu, W., Wang, H., Li, S., Liu, Q. and Sha, H. (2019) The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/Are Signaling Pathway in Chronic Diseases. Aging and Disease, 10, Article No. 637. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Chen, Q.M. and Maltagliati, A.J. (2018) Nrf2 at the Heart of Oxidative Stress and Cardiac Protection. Physiological Genomics, 50, 77-97. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Schafer, H., Geismann, C., Arlt, A. and Sebens, S. (2014) Cytoprotection “Gone Astray’’: Nrf2 and Its Role in Cancer. OncoTargets and Therapy, 7, 1497-1518. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Wall, S.B., Li, R., Butler, B., et al. (2021) Auranofin-Mediated Nrf2 Induction Attenuates Interleukin 1 Beta Expression in Alveolar Macrophages. Antioxidants, 10, 632.
|
|
[20]
|
Hayashi, R., Himori, N., Taguchi, K., Ishikawa, Y., Uesugi, K., Ito, M., et al. (2013) The Role of the Nrf2-Mediated Defense System in Corneal Epithelial Wound Healing. Free Radical Biology and Medicine, 61, 333-342. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Liu, S., Qin, T., Zou, F., Dong, H., Yu, L., Wang, H., et al. (2023) Pseudolaric Acid B Exerts an Antifungal Effect and Targets SIRT1 to Ameliorate Inflammation by Regulating Nrf2/NF-κB Pathways in Fungal Keratitis. Inflammopharmacology, 32, 1133-1146. [Google Scholar] [CrossRef] [PubMed]
|